Sanofi : la FDA approuve Sarclisa Escena, premier anticancéreux par injecteur portatif
La FDA a approuvé la formulation sous-cutanée de Sarclisa, administrée via un injecteur portatif (on-body injector), pour le traitement du myélome multiple. Le médicament devient le premier…
Read the full article3d agofr
You might also wanna read
Solving Indonesia’s LPG subsidy challenge requires induction, not swapping fuels
ieefa.org·just now
Analyse du marché de l'or et du 17 juillet
TradingView·26m ago
Higher Energy Costs May Boost Social Security COLA Next Year
The Daily Upside·27m ago
Wall Street Balks at TSMC’s $100 Billion Bet on Growing AI Demand
The Daily Upside·28m ago
Eli Lilly to Pay up to $3.8B for AtaiBeckley in Big Pharma’s Latest Psychedelic Foray
The Daily Upside·28m ago
Lackluster Retail Sales Mask a (Short-Lived) Silver Lining
The Daily Upside·28m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.